Logo of Huzzle

Home

Matches

Explore

Manage

Intern, Corporate Intelligence

image

BioMarin Pharmaceutical Inc.

Dec 24, 2023

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Science
  • San Francisco

Requirements

  • Required Skills:
  • Background in biological sciences
  • Able to collect and synthesize a wide range of data and information.
  • Strong analytical and project management skills
  • Excellent oral/written communication and presentation skills, including the ability to distill complex information into concise takeaways.
  • Excels at working collaboratively with others.
  • Focus on continuous improvement.
  • Qualifications/Eligibility:
  • Student pursing a Masters in a life science discipline, or in a PhD Program. Or MBA student with a Bachelors in life sciences.
  • Student must be returning to school in the Fall Term OR has graduated within the 1 year of the start of the program.
  • Must be available to work 40 hours a week.
  • Must be authorized to work in the United States without visa sponsorship.

Responsibilities

  • Landscape analysis for a therapeutic area, indication, and/or modality of interest and derivation of implications for BioMarin’s current portfolio and future development strategy
  • Analysis of recent technology trends in rare disease, including the development of new approaches and shifts in investment.
  • Company analysis to understand internal expertise and gaps, characterize previous/current strategic thinking, and predict future strategy.
image

BioMarin Pharmaceutical Inc.

We transform lives through genetic discovery.

Science & Healthcare
Industry
1001-5000
Employees
1997
Founded Year

Mission & Purpose

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.